Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Active not recruiting × Advanced NSCLC × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 77 Breast Neoplasms 49 Neoplasms 42 Colorectal Neoplasms 42 Neoplasm Metastasis 34 Melanoma 31 Prostatic Neoplasms 29 Multiple Myeloma 28 Stomach Neoplasms 27 Recurrence 26 Lung Neoplasms 26 Carcinoma, Renal Cell 26 Squamous Cell Carcinoma of Head and Neck 25 Pancreatic Neoplasms 24 Precursor Cell Lymphoblastic Leukemia-Lymphoma 23 Ovarian Neoplasms 23 Lymphoma, Large B-Cell, Diffuse 23 Triple Negative Breast Neoplasms 22 Lymphoma, Follicular 21 Leukemia, Myeloid, Acute 21 Lymphoma, Non-Hodgkin 20 Leukemia, Lymphocytic, Chronic, B-Cell 19 Glioblastoma 18 Lymphoma 17 Carcinoma, Transitional Cell 17 Uterine Cervical Neoplasms 16 Sarcoma 16 Myelodysplastic Syndromes 15 Colonic Neoplasms 15 Lymphoma, Mantle-Cell 14

Interventions

Oxaliplatin 1 Nivolumab 1 Ipilimumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04043195 2025-05-28

NSCLC

University of California, San Diego

Phase 1/2 Active not recruiting

Advanced NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡